Why Bank Your Stem Cells?
The banking of cord blood, cord tissue or placental cells is a medical issue which needs understanding. Recent researches have shown us where to look for mesenchymal stem cells, how to isolate them, how to recognize them with cytoplasmic markers, multiply them and convert them into progenitor cells for various therapies. Most importantly, how to cryopreserve them for subsequent use. Cord blood and cord tissue contain an abundance of stem cells that can easily be collected and banked (cryopreserved) in the event that they are needed later in life. These days stem cell banking is being done from, cord blood, Cord tissue, and Placenta. These are tissues which are normally discarded at the time of birth of a child. All these sources are sources are rich in stem cells, which can easily be procured, stem cells can be extracted, multiplied, and used for various therapies.
The umbilical cord fluid is loaded with stem cells. They can treat cancer, blood diseases like anemia, and more than 80 auto immune diseases, which disrupt your body’s ability to defend itself.
The fluid is easy to collect and has 10 times more stem cells than those collected from bone marrow.
Stem cells from cord blood rarely carry any infectious diseases and not likely to be rejected as adult stem cells.
Recent researches have shown that cord tissue has very large number of stem cells which can be extracted, multiplied, and are very vigorous cells which can be effectively used in the treatment of auto immune diseases. These cells can be cryopreserved and converted in to progenitor cells for regeneration of endogenous tissue cells.
Placental Stem Cells
Another source of stem cells is placenta. In addition to hematopoietic progenitors and HSCs, the placenta also enriches mesenchymal stem cells (MSCs). MSCs have a broad differentiation potential . MSCs from fetal membranes and placental tissue are able to differentiate into multiple lineage cell types including osteoblasts, chondrocytes, myocytes, adipocytes, and endothelial cell. Recent animal studies have shown that MSCs could be differentiated into beta-pancreatic islet cells and MSCs administration result in beta-pancreatic islet regeneration and prevent renal damage in diabetic animals. Mesenchymal stem cells are well tolerated by the host and can therefore avoid rejection. They interfere with T-cells mediated immunity by modulation to restore the normal immunogenic state.. These cells are able to secrete cytokines and generate a local immunosuppressive microenvironment.